// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
To help strengthen the pharmaceutical supply chain and guard against potential shortages that can
Over the past three decades, our medicines have become increasingly “globalized.” In the US alone
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis